Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population

Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population

PurposeTo describe the early experiences of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) whose treatment was switched to faricimab from other anti-vascular endothelial growth factor (VEGF) agents.MethodsThis is a prospective cohort of...

Full description

Bibliographic Details
Main Authors: Farah N. I. Ibrahim, Kelvin Y. C. Teo, Tien-En Tan, Hiok Hong Chan, Priya R. Chandrasekaran, Shu-Yen Lee, Anna C. S. Tan, Ranjana Mathur, Choi Mun Chan, Shaun S. Sim, Gavin Siew Wei Tan, Ian Y. S. Yeo, Chui Ming Gemmy Cheung
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Ophthalmology
Subjects:
ANG-2
anti-vegf
faricimab
neovascular age-related macular degeneration
polypoidal choroidal vasculopathy
switch therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fopht.2023.1346322/full

Internet

https://www.frontiersin.org/articles/10.3389/fopht.2023.1346322/full

Similar Items